Skip to content
Psilocybin Research
Menu
    MENUMENU
    • Home
      • About
      • Cognitive Neuroscience
      • Psychology
      • Lectures
      • Media
      • Statistics
      • Researchers
      • News
      • Contact
    • Psilocybin Facts
      • Ongoing/recently completed clinical trials
      • Psilocybin Patents
        • Top 100 Psilocybin patents
        • ≈1150 Psilocybin related patents
      • Molecular Structure & Chemical Details
      • Structural relatives of psilocybin
      • Psilocybin fungi taxonomies and their endemic habitat
      • The ancient history of psilocybin
    • Neuroscience
      • Neurochemical correlates of creativity
      • The default-mode network (DMN)
      • Psilocybin as a partial agonist of the 5-HT2A receptor
      • Psilocybin and neuroplasticity
      • Cross-modal synesthesia
      • The Adrenochrome Hypothesis of Schizophrenia
      • Psilocybin induced neurogenesis
      • Psilocybin and visual perception
    • Psychology
      • The origin of the term "psychedelic"
      • Psilocybin as a treatment for addiction
      • Psilocybin in the treatment of depressive disorders
      • Psilocybin as a therapeutic adjunct for PTSD
      • Psilocybin as a catalyst of spiritual experiences
      • Psilocybin and ego-dissolution
      • Psilocybin and near-death anxiety
      • Psilocybin and creativity
      • Psilocybin and metacognition
      • Psilocybin and visual perception
      • Psilocybin in a cross-cultural context
      • Psilocybin and shamanism
      • Cross-modal synesthesia
      • Mycelia networks, adaptogens, and mental health
    • Philosophy of Mind
      • The Knowledge Argument: The Ineffability of Qualia
    • Blog
    • Newsletter
    • Search

          • Intelligent AJAX search function

            Generic selectors
            Exact matches only
            Search in title
            Search in content
            Search in posts
            Search in pages

          • Site structure

            SiteMap Tree Interactive Mind Map

Tag: Epidemiology

Annecdotal evidence / Empirical studies / Misc

Psilocybin & Mental Health

Elsey, J. W. B. (2017). Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy. Drug Science, Policy and Law, 3, 205032451772323. Argento, E., …

Machine Learning Powered AI Translation

en English
af Afrikaansar العربيةbn বাংলাbg Българскиzh-CN 简体中文hr Hrvatskics Čeština‎da Dansknl Nederlandsen Englishtl Filipinofi Suomifr Françaisde Deutschel Ελληνικάgu ગુજરાતીiw עִבְרִיתhi हिन्दीit Italianoja 日本語ko 한국어lv Latviešu valodaml മലയാളംne नेपालीno Norsk bokmålfa فارسیpl Polskipt Portuguêsru Русскийsl Slovenščinaes Españolsv Svenskata தமிழ்th ไทยtr Türkçeur اردوzu Zulu

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Anything in here will be replaced on browsers that support the canvas element
  • Ego-dissolution
  • Creativity
  • Ego-death
  • Psilocybin Patents
  • Psilocybin Innovations
  • Schizophrenia
  • Shamanism
  • Albert Hofmann
  • Psilocybin
  • Hippocampus
  • 5-HT2A receptor
  • Neuroplasticity
  • Neurogenesis
  • Epidemiology
  • Suicidality
  • Mental Health
  • Openness to Experience
  • 5-Factor Model
  • Personality
  • Clinical Trials
  • Experimental Studies
  • Controlled Scientific Research

Recent Posts

  • Karry B. Mullis “Getting down with the molecules”
  • Psilocybin & Mental Health

Categories

Search Function

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Tags

5-Factor Model5-HT2A receptorAlbert HofmannClinical TrialsCreativityEgo-deathEgo-dissolutionEpidemiologyHippocampusMental HealthNeurogenesisNeuroplasticityOpenness to ExperiencePersonalityPsilocybinPsilocybin InnovationsPsilocybin PatentsSchizophreniaShamanismSuicidality

Categories

  • Annecdotal evidence
  • Empirical studies
  • Media reports
  • Misc

Translation

en English
af Afrikaansar العربيةbn বাংলাbg Българскиzh-CN 简体中文hr Hrvatskics Čeština‎da Dansknl Nederlandsen Englishtl Filipinofi Suomifr Françaisde Deutschel Ελληνικάgu ગુજરાતીiw עִבְרִיתhi हिन्दीit Italianoja 日本語ko 한국어lv Latviešu valodaml മലയാളംne नेपालीno Norsk bokmålfa فارسیpl Polskipt Portuguêsru Русскийsl Slovenščinaes Españolsv Svenskata தமிழ்th ไทยtr Türkçeur اردوzu Zulu

Psilocybin Newsletter

Quotation

When we look within ourselves with psilocybin, we discover that we do not have to look outward toward the futile promise of life that circles distant stars in order to still our cosmic loneliness. We should look within; the paths of the heart lead to nearby universes full of life and affection for humanity.Terrence McKenna (*1946;†2000)
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
(CC) 2016— by Dr. Christopher B. Germann (PhD, MSc, BSc, Marie Curie Alumnus)
https://neuropsy-webdesign.de
The project www.Psilocybin-Research.com was funded by the EU Marie Curie Initial Training Network FP7-PEOPLE-2013-ITN-604764
→ Primary goals of research and innovation policy as defined by the European Comission: Open Innovation, Open Science, Open to the World.
https://www.cognovo.eu/people/research-fellows/christopher-germann.php

Legal disclaimer: The interdisciplinary Marie Curie CogNovo program has been intentionally designed by the European Union and the University of Plymouth (United Kingdom) to discuss and disseminate a wide view on a diverse spectrum of topics including psychology, neuroscience, current affairs, basic science, humanities, and the arts, inter alia. Note that the views and opinions expressed on this website do not necessarily represent the opinions of any of the institutions mentioned on this website and belong exclusively to the copyright holder. The CogNovo program explicitly emphasises cognitive and social innovation, the generation of new ideas and perspectives, and the probing of boundaries, but see https://www.cognovo.eu/about/
Copyright © 2019 Psilocybin Research – OnePress theme by FameThemes